Mettler-Toledo International (NYSE:MTD) Releases FY 2026 Earnings Guidance

Mettler-Toledo International (NYSE:MTD) issued an update on its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 47.150-47.500 for the period, compared to the consensus earnings per share estimate of 46.640. The company issued revenue guidance of $4.2 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Mettler-Toledo International also updated its Q3 2026 guidance to 12.000-12.150 EPS.

Mettler-Toledo International Trading Up 2.7%

Shares of Mettler-Toledo International stock traded up $37.94 during trading on Friday, reaching $1,418.55. The company’s stock had a trading volume of 257,196 shares, compared to its average volume of 178,393. The stock has a market capitalization of $28.67 billion, a P/E ratio of 33.27, a price-to-earnings-growth ratio of 2.90 and a beta of 1.24. Mettler-Toledo International has a one year low of $1,023.05 and a one year high of $1,525.17. The stock has a 50-day moving average price of $1,231.02 and a two-hundred day moving average price of $1,275.04.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping analysts’ consensus estimates of $10.80 by $0.66. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the previous year, the firm posted $10.09 earnings per share. The company’s revenue was up 4.5% on a year-over-year basis. As a group, sell-side analysts anticipate that Mettler-Toledo International will post 46.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on MTD shares. Robert W. Baird reduced their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. JPMorgan Chase & Co. lowered their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Morgan Stanley dropped their target price on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Citigroup dropped their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Finally, Barclays lowered their target price on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Six equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $1,420.36.

Key Stories Impacting Mettler-Toledo International

Here are the key news stories impacting Mettler-Toledo International this week:

• Positive Sentiment: Second-quarter earnings beat estimates: Adjusted EPS was $11.46, up 14% from $10.09 a year earlier and $0.66 above the $10.80 consensus estimate. Reported diluted EPS was $11.55, compared with $9.76 in the prior-year quarter. Mettler-Toledo International Reports Second Quarter 2026 Results
• Positive Sentiment: Healthy sales growth: Second-quarter reported sales increased 4% year over year to approximately $1.03 billion. In local currency, sales rose 6% excluding a one-time tariff refund to customers, indicating stronger underlying demand than the reported growth rate suggests. Mettler-Toledo Q2 Earnings Snapshot
• Positive Sentiment: Full-year outlook raised: Mettler-Toledo issued fiscal 2026 EPS guidance of $47.15 to $47.50, above the prior consensus estimate of $46.64. The higher forecast reinforces investor confidence in earnings momentum and supports the stock’s positive reaction. Mettler-Toledo International Q2 2026 Earnings
• Neutral Sentiment: Third-quarter guidance is broadly consistent with expectations: EPS guidance of $12.00 to $12.15 brackets the $12.12 consensus estimate, while revenue guidance of approximately $1.1 billion is in line with forecasts. Mettler-Toledo Q2 2026 Earnings Call Transcript

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MTD. DV Equities LLC purchased a new position in Mettler-Toledo International in the fourth quarter valued at approximately $40,000. Quantbot Technologies LP bought a new position in Mettler-Toledo International during the third quarter valued at approximately $49,000. State of Wyoming bought a new position in shares of Mettler-Toledo International in the second quarter worth approximately $58,000. Kelleher Financial Advisors purchased a new stake in Mettler-Toledo International in the 3rd quarter worth approximately $61,000. Finally, MUFG Securities EMEA plc bought a new position in Mettler-Toledo International in the second quarter worth about $72,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.